Andras lacko
About Us
About Andras lacko
Dr. Lacko is Professor Emeritus at the University of North Texas Health Science Center where he has acquired over 40 years of experience in lipoprotein research and over thirty years of experience in the preparation, characterization and performance evaluation of drug carrying nanoparticles. His current research involves evaluation of a lipoprotein based, biocompatible drug delivery system, primarily directed toward cancer chemotherapy.
Dr. Lacko has contributed to approved patents with leading US investigators at MD Anderson Cancer Center and at the NIH. His current interests include the establishment of a private venture to allow the clinical utilization and commercialization of their latest technology in therapeutic drug delivery.
- Shahzad MMK et al. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles, Neoplasia 2011;13(4):309-19. doi: 10.1593/neo.101372.
- Raut S. et al. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence. J Pharmacol Exp Ther. 2020; 373(1):113-121. PMID: 31941718.
- Sabnis N. etal. A Spontaneous Assembling Lipopeptide Nanoconjugate Transporting the Anthracycline Drug N-Benzyladriamycin-14-valerate for Personalized Therapy of Ewing Sarcoma. Bioconjug Chem. 2024; 35(2):187-202. doi:10.1021/acs.bioconjchem. 3c00429.